Stay updated on Tislelizumab After Liver-Directed Therapy Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab After Liver-Directed Therapy Clinical Trial page.

Latest updates to the Tislelizumab After Liver-Directed Therapy Clinical Trial page
- Check7 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding/operating status notice (and Revision: v3.4.1) from the page.SummaryDifference0.4%

- Check14 days agoChange DetectedAdded a government-funding notice and updated the site revision to v3.4.1, replacing the prior v3.4.0.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page now shows a glossary toggle and updated update-history labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with a new revision note v3.4.0. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.SummaryDifference0.2%

- Check28 days agoChange DetectedThe changes seem to reflect updates to page timestamps and metadata (e.g., last update posted 2026-01-20) rather than alterations to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page shows a new Revision: v3.3.4, replacing the prior Revision: v3.3.3; this is a minor technical update with no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded a consolidated Locations section with New Jersey and New York sites, removed the separate 'New Jersey Locations' and 'New York Locations' headings, and updated the page to revision v3.3.3.SummaryDifference0.3%

Stay in the know with updates to Tislelizumab After Liver-Directed Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab After Liver-Directed Therapy Clinical Trial page.